Eyenovia Stock Analysis

Eyenovia Stock Analysis Notes

About 14.0% of the company shares are held by institutions such as insurance companies. The book value of Eyenovia was currently reported as 0.2. The company recorded a loss per share of 0.69. Eyenovia had not issued any dividends in recent years. Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York. Eyenovia operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people. To learn more about Eyenovia call Michael Rowe at 833 393 6684 or check out https://www.eyenovia.com.

Eyenovia Investment Alerts

Eyenovia Upcoming and Recent Events

Eyenovia Largest EPS Surprises

View All Earnings Estimates

Eyenovia Stock Institutional Investors

Note, although Eyenovia's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Eyenovia Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.45 M.

Eyenovia Profitablity

Management Efficiency

Eyenovia has return on total asset (ROA) of (0.9294) % which means that it has lost $0.9294 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (9.1466) %, meaning that it created substantial loss on money invested by shareholders. Eyenovia's management efficiency ratios could be used to measure how well Eyenovia manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of December 2024, Return On Tangible Assets is likely to drop to -1.07. In addition to that, Return On Capital Employed is likely to drop to -1.39. At this time, Eyenovia's Debt To Assets are very stable compared to the past year.

Technical Drivers

As of the 1st of December, Eyenovia shows the Mean Deviation of 6.68, variance of 145.8, and Standard Deviation of 12.07. Eyenovia technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Eyenovia Price Movement Analysis

Eyenovia Insider Trading Activities

Eyenovia Outstanding Bonds

Eyenovia Predictive Daily Indicators

Eyenovia Forecast Models

Eyenovia's time-series forecasting models are one of many Eyenovia's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Eyenovia's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Eyenovia prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Eyenovia shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Eyenovia. By using and applying Eyenovia Stock analysis, traders can create a robust methodology for identifying Eyenovia entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Eyenovia analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Eyenovia analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Eyenovia stock analysis indicators help investors evaluate how Eyenovia stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Eyenovia shares will generate the highest return on investment. By understating and applying Eyenovia stock analysis, traders can identify Eyenovia position entry and exit signals to maximize returns.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.